Showing results (31-40 of 352) with videos related to
Sort By:
Pageof 36
BMC Health Services Research|June 2, 2022
Public legitimacy of healthcare resource allocation committees: lessons learned from assessing an Israeli case studyYael Assor, Dan GreenbergHealth Policy (Amsterdam, Netherlands)|June 27, 2008
Estimating the budget impact of new technologies added to the National List of Health Services in Israel: stakeholders' incentives for adopting a financial risk-sharing mechanismAriel Hammerman, Dan GreenbergExpert Review of Pharmacoeconomics & Outcomes Research|March 10, 2017
Using lower cost statins improves outcomes for normal cholesterol non-diabetic patientsRonen Arbel, Dan GreenbergInternational Journal for Equity in Health|February 26, 2016
Rethinking cost-effectiveness in the era of zero healthcare spending growthRonen Arbel, Dan GreenbergClinicoeconomics and Outcomes Research : CEOR|October 23, 2014
A medicoeconomic review of early intervention with biologic agents in the treatment of inflammatory bowel diseasesShmuel Odes, Dan GreenbergHarefuah|September 21, 2012
[Risk-sharing schemes: a new paradigm in adopting innovative pharmaceuticals]Ariel Hammerman, Dan GreenbergHaemophilia : the Official Journal of the World Federation of Hemophilia|January 25, 2022
Health technology assessment for gene therapies in haemophiliaJamie O'Hara, Peter J Neumann, Expert Review of Pharmacoeconomics & Outcomes Research|August 28, 2013
Does framing of cancer survival affect perceived value of care? A willingness-to-pay survey of US residentsPei-Jung Lin, Thomas W Concannon, Dan Greenberg, et al.Zeitschrift Fur Kardiologie|March 19, 2003
Examining the economic impact of restenosis: implications for the cost-effectiveness of an antiproliferative stentDan Greenberg, David J CohenThe Israel Medical Association Journal : IMAJ|March 6, 2002
Laparoscopic versus open appendectomy: results of a retrospective comparison in an Israeli hospitalJochanan G Peiser, Dan GreenbergPageof 36